Role of amyloid β1-42 and neuroimaging biomarkers in Alzheimer's disease

被引：0
|
作者：
Lista, Simone [1 ]
Emanuele, Enzo [2 ]
机构：
[1] Univ Roma Tor Vergata, Ctr Pharmaceut Biotechnol, I-00133 Rome, Italy
[2] Living Res Sas, I-27038 Robbio, PV, Italy
来源：
BIOMARKERS IN MEDICINE | 2011年 / 5卷 / 04期
关键词：
Alzheimer's disease; amyloid beta 1-42; amyloid plaques; biomarker; cerebrospinal fluid; mild cognitive impairment; MRI; DIAGNOSIS;
D O I：
10.2217/BMM.11.50
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：411 / 413
页数：3
相关论文
共 50 条
  • [1] CSF tau and amyloid β1-42 (Aβ42) as possible biomarkers of Alzheimer disease
    Ravid, R
    Kamphorst, W
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2005, 238 : S298 - S298
  • [2] CSF Aβ1-42 combined with neuroimaging biomarkers in the early detection, diagnosis and prediction of Alzheimer's disease
    Lista, Simone
    Garaci, Francesco G.
    Ewers, Michael
    Teipel, Stefan
    Zetterberg, Henrik
    Blennow, Kaj
    Hampel, Harald
    ALZHEIMERS & DEMENTIA, 2014, 10 (03) : 381 - 392
  • [3] Plasma amyloid β-peptide 1-42 and incipient Alzheimer's disease
    Mayeux, R
    Tang, MX
    Jacobs, DM
    Manly, J
    Bell, K
    Merchant, C
    Small, SA
    Stern, Y
    Wisniewski, HM
    Mehta, PD
    ANNALS OF NEUROLOGY, 1999, 46 (03) : 412 - 416
  • [4] A systematic review and meta-analysis of plasma amyloid 1-42 and tau as biomarkers for Alzheimer's disease
    Shanthi, Keerthanaa Balasubramanian
    Krishnan, Sreeram
    Rani, P.
    SAGE OPEN MEDICINE, 2015, 3
  • [5] The Unexpected Role of Aβ1-42 Monomers in the Pathogenesis of Alzheimer's Disease
    Tamagno, Elena
    Guglielmotto, Michela
    Monteleone, Debora
    Manassero, Giusi
    Vasciaveo, Valeria
    Tabaton, Massimo
    JOURNAL OF ALZHEIMERS DISEASE, 2018, 62 (03) : 1241 - 1245
  • [6] Mechanical manipulation of Alzheimer's amyloid β1-42 fibrils
    Karsai, A.
    Martonfalvi, Zs.
    Nagy, A.
    Grama, L.
    Penke, B.
    Kellermayer, M. S. Z.
    JOURNAL OF STRUCTURAL BIOLOGY, 2006, 155 (02) : 316 - 326
  • [7] Mechanism of interaction of Alzheimer's disease drugs with aggregates of β- amyloid peptide (Aβ 1-42)
    Ramakrishnan, Latha
    Bhattarai, Nirjal
    Henning, Phillip P.
    Rajbhandari, Labchan
    Thapa, Rajan B.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 237 : 421 - 421
  • [8] Plasma Levels of Amyloid β1-42 Are Independent of Neuronal Function in Alzheimer's Disease
    Sedaghat, Fereshteh
    Dedousi, Eleni
    Costa, Vasiliki
    Dimitriadis, Athanasios S.
    Baloyannis, Stavros J.
    JOURNAL OF ALZHEIMERS DISEASE, 2009, 17 (02) : 343 - 348
  • [9] Cerebrospinal Fluid Levels of Amyloid Beta 1-43 Mirror 1-42 in Relation to Imaging Biomarkers of Alzheimer's Disease
    Almdahl, Ina S.
    Lauridsen, Camilla
    Selnes, Per
    Kalheim, Lisa F.
    Coello, Christopher
    Gajdzik, Beata
    Moller, Ina
    Wettergreen, Marianne
    Grambaite, Ramune
    Bjornerud, Atle
    Brathen, Geir
    Sando, Sigrid B.
    White, Linda R.
    Fladby, Tormod
    FRONTIERS IN AGING NEUROSCIENCE, 2017, 9
  • [10] Alzheimer's amyloid β peptide (1-42) fibrils are not always neurotoxic
    Varadarajan, S
    Yatin, S
    Butterfield, DA
    ALZHEIMERS REPORTS, 2000, 3 (02): : 71 - 76
12345